These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 2543013
1. Inhibitory effect of a selective kappa receptor agonist, U-50, 488H, on methamphetamine-elicited ipsilateral circling behavior in rats with unilateral nigral lesions. Ohno M, Yamamoto T, Ueki S. Psychopharmacology (Berl); 1989; 97(2):219-21. PubMed ID: 2543013 [Abstract] [Full Text] [Related]
2. Ventral pallidal microinjections of receptor-selective opioid agonists produce differential effects on circling and locomotor activity in rats. Hoffman DC, West TE, Wise RA. Brain Res; 1991 Jun 07; 550(2):205-12. PubMed ID: 1653084 [Abstract] [Full Text] [Related]
3. The selective kappa-opioid agonist, U-50,488H, produces antinociception in the rat via a supraspinal action. Czlonkowski A, Millan MJ, Herz A. Eur J Pharmacol; 1987 Oct 06; 142(1):183-4. PubMed ID: 2826175 [No Abstract] [Full Text] [Related]
4. Effects of a selective kappa-opioid agonist, U-50,488H, on morphine dependence in rats. Fukagawa Y, Katz JL, Suzuki T. Eur J Pharmacol; 1989 Oct 24; 170(1-2):47-51. PubMed ID: 2558895 [Abstract] [Full Text] [Related]
5. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration. Wilson JL, Nayanar V, Walker JS. Br J Pharmacol; 1996 Aug 24; 118(7):1754-60. PubMed ID: 8842441 [Abstract] [Full Text] [Related]
15. Denervation-like postsynaptic supersensitivity to dopamine agonists induced by microinjection of colchicine into the substantia nigra pars compacta. Kamata K, Kameyama T, Okuyama S, Hashimoto S, Aihara H. Brain Res; 1986 Mar 05; 367(1-2):1-7. PubMed ID: 3008917 [Abstract] [Full Text] [Related]
16. Effect of the kappa-receptor agonist, U-50,488H, on cerebral ischemia-induced impairment of working memory assessed in rats by a three-panel runway task. Ohno M, Yamamoto T, Ueki S. Eur J Pharmacol; 1991 Feb 14; 193(3):357-61. PubMed ID: 1647321 [Abstract] [Full Text] [Related]
17. Effect of chronic administration of U-50,488H, a kappa-opioid receptor agonist, on central dopamine D2 receptors of the rat. Veeranna, Reddy PL, Bhargava HN. Eur J Pharmacol; 1993 Apr 22; 235(1):23-30. PubMed ID: 8390939 [Abstract] [Full Text] [Related]
18. Binding characteristics of [3H]SCH 23390 in spinal cord and discrete brain regions of kappa-opiate tolerant-dependent and abstinent rats. Bhargava HN, Gulati A, Ramarao P. Pharmacology; 1991 Apr 22; 42(3):121-7. PubMed ID: 1647533 [Abstract] [Full Text] [Related]
19. The kappa-opioid U-50,488H suppresses the initiation of nocturnal spontaneous drinking in normally hydrated rats. Badiani A, Stewart J. Psychopharmacology (Berl); 1992 Apr 22; 106(4):463-73. PubMed ID: 1315973 [Abstract] [Full Text] [Related]
20. Non-competitive antagonism of N-methyl-D-aspartate receptor inhibits tolerance to the analgesic action of U-50,488H, a kappa-opiate receptor agonist in the rat. Bhargava HN. Gen Pharmacol; 1995 Sep 22; 26(5):1055-60. PubMed ID: 7557250 [Abstract] [Full Text] [Related] Page: [Next] [New Search]